+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Peptide t treatment of cognitive impairment in hiv positive intravenous drug abusers



Peptide t treatment of cognitive impairment in hiv positive intravenous drug abusers



Society for Neuroscience Abstracts 17(1-2): 1595




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032749450

Download citation: RISBibTeXText


Related references

Peptide T Treatment of Cognitive Impairment in HIV-Positive Intravenous Drug Users. American Journal on Addictions 1(4): 332-338, 1992

Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug & Alcohol Dependence 71(2): 207-211, 20 August, 2003

Impairment of t lymphocyte subsets by hbv and hiv infections in immunocompromised intravenous drug abusers. International Journal of Immunopathology & Pharmacology 3(2 SUPPL): 147-150, 1990

HIV-specific changes in the motor performance of HIV-positive intravenous drug abusers. Journal Of Neurology. 242(1): 20-25, 1994

Chlamydia pneumoniae infection in hiv 1 positive intravenous drug abusers. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b164, 1992

The AIDS autopsy: comparison of intravenous drug abusers with non-intravenous drug abusers. Progress in Aids Pathology 1: 219-229, 1989

Neurocognitive impairment related to acquired immunodeficiency syndrome in socially-excluded former intravenous drug abusers. Enfermedades Infecciosas Y Microbiologia Clinica 28(5): 294-296, 2010

Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study. Journal of Neuropsychiatry and Clinical Neurosciences 9(1): 29-36, 1997

Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment. Journal of Psychoactive Drugs 35(2): 209-218, 2003

Staphylococcus aureus endocarditis in hiv positive and hiv negative intravenous drug abusers. Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 269, 1989

Do cannabis drug abusers differ from intravenous drug abusers? The role of social and behavioural risk factors. British Journal of Addiction 87(2): 259-266, 1992

Htlv 1 2 co infection among 3133 hiv positive intravenous drug abusers from lombardy italy. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 164, 1991

Marked increase in benzodiazepine requirements during bronchoscopy in HIV positive intravenous drug abusers. Irish Medical Journal 85(1): 37-38, 1992

Female prostitutes comparison between intravenous drug abusers and nonintravenous drug abusers for the risk of human t cell lymphotropic virus type iii infection. Proceedings American Society of Clinical Oncology Annual Meeting 5: 7, 1986

Htlv i seroprevalence in a group of hiv 1 positive italian subjects intravenous drug abusers majority. Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 162, 1989